Literature DB >> 23100906

Trifluoperazine and CEF-allicin from garlic (Allium sativum) as potential new antitubercular drugs active against drug resistantMycobacterium tuberculosis.

P S Murthy1, P Ratnakar, D V Gadre, V Talwar, H C Gupta, R L Gupta.   

Abstract

Trifluoperazine (TFP) and a compound called CEF-allicin purified from garlic (Allium sativum) possess antitubercular activity against both drug susceptible and resistant clinical isolates ofMycobacterium tuberculosis. They are bactericidal in nature with multiple sites of primary action. This new use for known drug TFP was based on our observation that mycobacteria have calmodulin like protein which regulates their metabolism and a calmodulin antagonist has antitubercular activity. The minimum inhibitory concentration (MIC) of TFP againstM. tuberculosis was 4-5 μg/ml. It inhibited considerably by 6hrs, the synthesis of total lipids from(14)C-acetate and proteins and DNA as judged by the uptake of(14)C-glycine and(3)H-thymidine respectively by the bacilli. With 50 clinical isolates from our hospital at Delhi, the MIC was 4μg/ml, for 40% and 8μg/ml, for 50% of the isolates susceptible as well as resistant to one or more of the five drugs isoniazid, rifampicin, streptomycin, ethambutol and pyrazinamide. The MIC of CEF-allicin was 25μg/ml, for bothMycobacterium tuberculosis and isoniazid resistant clinical isolate TRC-C 1193. It inhibited in 6hrs or less the synthesis of total lipids completely and proteins and DNA ofM. tuberculosis from its labeled precursors almost completely.

Entities:  

Keywords:  Allium sativum; Mycobacterium tuberculosis; Trifluoperazine; allicin; antitubercular drugs; garlic; multi drug resistance

Year:  1997        PMID: 23100906      PMCID: PMC3454315          DOI: 10.1007/BF02873066

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  6 in total

1.  Investigations on plant antibiotics; studies on allicin, the antibacterial principle of Allium sativum (garlic).

Authors:  R RAGHUNANDANA RAO; S SRINIVASA RAO; P R VENKATARAMAN
Journal:  J Sci Ind Res (1942)       Date:  1946-08

2.  Effect of trifluoperazine on in vitro ATP synthesis by Mycobacterium leprae.

Authors:  V M Katoch; N Saxena; C T Shivannavar; V D Sharma; K Katoch; R K Sharma; P S Murthy
Journal:  FEMS Immunol Med Microbiol       Date:  1998-02

3.  Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv.

Authors:  P Ratnakar; P S Murthy
Journal:  FEMS Microbiol Lett       Date:  1993-07-01       Impact factor: 2.742

4.  Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis.

Authors:  D V Gadre; V Talwar; H C Gupta; P S Murthy
Journal:  Int Clin Psychopharmacol       Date:  1998-05       Impact factor: 1.659

5.  Antitubercular activity of trifluoperazine, a calmodulin antagonist.

Authors:  P Ratnakar; P S Murthy
Journal:  FEMS Microbiol Lett       Date:  1992-10-01       Impact factor: 2.742

6.  Correlation between calmodulin-like protein, phospholipids, and growth in glucose-grown Mycobacterium phlei.

Authors:  P H Reddy; S S Burra; P S Murthy
Journal:  Can J Microbiol       Date:  1992-04       Impact factor: 2.419

  6 in total
  1 in total

1.  Studies on a new antitubercular drug, trifluoperazine: Its effect in combination with conventional antitubercular drugs in tubercular lymphadenitis.

Authors:  R L Gupta; S Jain; V Talwar; H C Gupta; P S Murthy
Journal:  Indian J Clin Biochem       Date:  1998-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.